Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
RPID Rapid Micro Biosystems
1.210-0.100-7.63%
Close
02/08 16:00 ET
1.2100.0000.00%
Post Mkt Price 02/08 16:01 ET
High
1.430
Open
1.350
Turnover
135.96K
Low
1.170
Pre Close
1.310
Volume
109.50K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Rapid Micro Biosystems Sees Q4 Revenue $4.2M-$4.4M, Consensus $4.5M
Press Release: Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Revenue
Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Revenue Full year 2022 commercial revenue expected to be between $17.0 million and $17.2 million Finished 202
Rapid Micro Biosystems Announces Preliminary Unaudited Q4 And FY22 Revenue; Sees Q4 Revenue Between $4.2M-$4.4M; Sees FY22 Revenue Between $17M-$17.2M
Full year 2022 commercial revenue expected to be between $17.0 million and $17.2 millionFinished 2022 with approximately $140 million in cash and investments providing runway at least into 2026Company
Rapid Micro Biosystems (NASDAQ:RPID) Vs. Seer (NASDAQ:SEER) Critical Analysis
Rapid Micro Biosystems (NASDAQ:RPID – Get Rating) and Seer (NASDAQ:SEER – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based
Analyzing Rapid Micro Biosystems (NASDAQ:RPID) and Seer (NASDAQ:SEER)
Rapid Micro Biosystems (NASDAQ:RPID – Get Rating) and Seer (NASDAQ:SEER – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based
Rapid Micro Biosystems to Present at 41st Annual J.P. Morgan Healthcare Conference
LOWELL, Mass., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the "Company"), an innovative life sciences technology company providing mission critical automation sol
Rapid Micro Biosystems's Return On Capital Employed Overview
Benzinga Pro data, Rapid Micro Biosystems (NASDAQ:RPID) reported Q3 sales of $4.74 million. Earnings fell to a loss of $16.34 million, resulting in a 24.82% decrease from last quarter. Rapid Micro Bio
Rapid Micro Biosystems Publishes Colony Counting Data in Journal
Rapid Micro Biosystems Announces Publication Of A Multi-Author Case Study Supporting Fully Automated Colony Counting In Pharmaceutical Microbiology
Rapid Micro Biosystems, Inc. (NASDAQ:RPID) (the "Company"), an innovative life sciences technology company, providing mission critical automation solutions to facilitate the efficient manufacturing an
Rapid Micro Biosystems Shares Drop 17% After Review Yields No Buyers
By Chris Wack Rapid Micro Biosystems Inc. shares were down 17% to $1.71 after the company said its board of directors has concluded its previously announced review of strategic alternatives, and plan
Company Overview
More
Rapid Micro Biosystems, Inc. is an innovative life sciences technology company. It provides mission critical automation solutions to facilitate the efficient manufacturing and safe release of healthcare products such as biologics, vaccines, cell & gene therapies, and sterile injectable. The company was founded by Donald Straus in 2006 and is headquartered in Lowell, MA.
CEO： Mr. Robert Spignesi
Market： NASDAQ
Listing Date： 07/15/2021
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet